Quick Answer
BIOXYTRAN, INC reported Net Income Loss of -$2.37 million for the year ending 2024.
- BIOXYTRAN, INC showed an increase of +47.1% in Net Income Loss from 2023 to 2024.
- This data is from BIOXYTRAN, INC's annual report (Form 10-K), filed with the SEC on April 3, 2025.
- XBRL data for this metric is available from 2011 to 2024 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2011 to 2024), BIOXYTRAN, INC's Net Income Loss has grown by 46.6%.
- Historical annual values: Fiscal year 2024: -$2.37 million | Fiscal year 2023: -$4.47 million | Fiscal year 2022: -$2.46 million | Fiscal year 2021: -$4.03 million | Fiscal year 2020: -$2.54 million | Fiscal year 2019: -$1.86 million | Fiscal year 2018: -$296.4 thousand | Fiscal year 2017: -$318.4 thousand | Fiscal year 2016: -$696.8 thousand | Fiscal year 2015: -$2.10 million | Fiscal year 2014: -$1.35 million | Fiscal year 2013: -$1.78 million | Fiscal year 2012: -$2.29 million | Fiscal year 2011: -$4.43 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: